Injectafer Side Effects

Generic Name: ferric carboxymaltose

Note: This document contains side effect information about ferric carboxymaltose. Some of the dosage forms listed on this page may not apply to the brand name Injectafer.

For the Consumer

Applies to ferric carboxymaltose: intravenous solution

Along with its needed effects, ferric carboxymaltose (the active ingredient contained in Injectafer) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking ferric carboxymaltose:

• Blurred vision
• confusion
• dizziness
• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
• feeling of warmth
• headache
• nervousness
• pounding in the ears
• redness of the face, neck, arms, and occasionally, upper chest
• slow or fast heartbeat
• sweating
• unusual tiredness or weakness

• Chest discomfort
• chills
• cough
• difficult or labored breathing
• difficulty swallowing
• fainting
• fast, pounding, or irregular heartbeat or pulse
• fever
• hives
• itching
• large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
• skin rash
• tightness in the chest

Some side effects of ferric carboxymaltose may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

• Nausea

• Change in taste
• discoloration at the injection site
• loss of taste
• vomiting

• Abdominal or stomach pain
• burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
• diarrhea
• difficulty having a bowel movement (stool)
• pain or irritation at the injection site
• sneezing

• Back pain
• difficulty with moving
• hives or welts
• muscle pain or stiffness
• pain in the joints
• redness of the skin

For Healthcare Professionals

Applies to ferric carboxymaltose: intravenous solution

Cardiovascular

Common (1% to 10%): Flushing/hot flush, hypertension, hypotension
Uncommon (0.1% to 1%): Chest pain, peripheral edema, tachycardia
Rare (less than 0.1%): Phlebitis
Postmarketing reports: Chest discomfort, pallor^[Ref]

Dermatologic

Uncommon (0.1% to 1%): Erythema, rash, pruritus, urticaria
Postmarketing reports: Angioedema, dermatitis^[Ref]

Gastrointestinal

Common (1% to 10%): Nausea, vomiting
Uncommon (0.1% to 1%): Abdominal pain, constipation, diarrhea, dyspepsia
Rare (less than 0.1%): Flatulence^[Ref]

Hepatic

Common (1% to 10%): Alanine aminotransferase increase
Uncommon (0.1% to 1%): Aspartate aminotransferase increase, gamma glutamyl transferase increase^[Ref]

Hypersensitivity

Common (1% to 10%): Pruritus, rash, urticaria, wheezing, and hypertension associated with hypersensitivity reactions
Rare (less than 0.1%): Serious anaphylactic/anaphylactoid reactions^[Ref]

Local

Common (1% to 10%): Injection site reactions^[Ref]

Injection site reactions include infusion site burning, -pain, -bruising, -discoloration, -extravasation, -irritation, and -paresthesia.^[Ref]

Metabolic

Common (1% to 10%): Blood phosphorus decrease, hypophosphatemia
Uncommon (0.1% to 1%): Blood alkaline phosphatase increase, blood lactate dehydrogenase increase^[Ref]

Musculoskeletal

Postmarketing reports: Arthralgia, back pain, hypophosphatemic osteomalacia, muscle spasms, myalgia^[Ref]

Nervous system

Common (1% to 10%): Dizziness, dysgeusia, headache
Uncommon (0.1% to 1%): Paraesthesia
Rare (less than 0.1%): Syncope, presyncope
Postmarketing reports: Loss of consciousness^[Ref]

Other

Uncommon (0.1% to 1%): Chills, fatigue, pain, pyrexia
Rare (less than 0.1%): Malaise, rigors
Frequency not reported: Overestimate of serum iron and transferrin bound iron laboratory assays
Postmarketing reports: Face edema, vertigo^[Ref]

Respiratory

Uncommon (0.1% to 1%): Sneezing
Rare (less than 0.1%): Bronchospasm
Postmarketing reports: Dyspnea^[Ref]

Psychiatric

Rare (less than 0.1%): Anxiety^[Ref]

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer